Helen Sabzevari - Jan 4, 2023 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
President and CEO, Director
Signature
/s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact
Stock symbol
PGEN
Transactions as of
Jan 4, 2023
Transactions value $
$0
Form type
4
Date filed
1/6/2023, 03:05 PM
Previous filing
Jun 15, 2022
Next filing
Jan 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGEN Common Stock Options Exercise +17.7K +1.97% 915K Jan 4, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGEN Restricted Stock Units Options Exercise $0 -17.7K -100% $0.00* 0 Jan 4, 2023 Common Stock 17.7K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F2 The RSUs were granted on January 4, 2019 and January 25, 2019 and have vested in full.